INTRODUÇÃO: A interação entre leucócitos e plaquetas é fundamental para o início e a progressão da reestenose e da aterosclerose. Recentemente foi evidenciado em estudos in vitro que a integrina Mac-1 dos leucócitos se liga à glicoproteína Ibalfa (GP Ibalfa) das plaquetas e que esta interação possui uma função central na firme adesão e transmigração de leucócitos em locais de deposição de plaquetas. Entretanto, não há estudos in vivo que avaliam a importância da interação entre a integrina Mac-1 dos leucócitos e a GP Ibalfa das plaquetas (alfaMbeta2-GP Ibalfa) em modelo experimental de lesão vascular. MÉTODO: Um peptídeo denominado M2 ou anticorpo anti-M2 foi desenvolvido para bloquear a interação da integrina Mac-1 dos leucócitos com a GP Ibalfa das plaquetas, visando, deste modo, inibir a adesão de leucócitos na superfície do vaso coberta por plaquetas, a proliferação celular e a hiperplasia neointimal. Este peptídeo foi injetado e comparado com anticorpo-controle em camundongos C57B1/6J submetidos à lesão vascular da artéria femoral com corda-guia. Um dia (controle: n= 6; anti-M2: n= 6), 5 dias (controle: n= 9; anti-M2: n= 9) ou 28 dias (controle: n= 9; anti-M2: n= 9) após a lesão vascular, as artérias femorais foram retiradas para a realização de morfometria e imunohistoquímica. RESULTADOS: O bloqueio da interação alfaMbeta2-GP Ibalfa promoveu redução estatisticamente significativa de 75% do número de leucócitos na camada média no primeiro dia após a lesão vascular (controle: 7,9 ± 5,0% do total de células na camada média; versus anti-M2: 2,0 ± 1,6%; p=0,021), bem como determinou diminuição estatisticamente significativa de 42% em 5 dias (controle: 42,3 ± 12,9% do total de células na neoíntima; versus anti-M2: 24,6 ± 10,8%; p=0,047) e de 58% em 28 dias do acúmulo de leucócitos na neoíntima em desenvolvimento (controle: 7,9 ± 3,0% versus anti-M2: 3,3 ± 1,3%; p=0,012). A proliferação celular na camada média do vaso em 5 dias pós-lesão vascular apresentou redução estatisticamente significativa de 64% com o bloqueio da interação alfaMbeta2-GP Ibalfa (controle: 5,0 ± 2,9% do total de células na camada média; versus anti-M2: 1,8 ± 0,5%; p=0,043), assim como houve diminuição significativa de 47% da proliferação celular na camada íntima do vaso em 28 dias (controle: 3,8 ± 1,7% do total de células na camada íntima; versus anti-M2: 2,0 ± 1,2%; p=0,047). O bloqueio da interação alfaMbeta2-GP Ibalfa também determinou redução estatisticamente significativa de 56% do espessamento intimal em 28 dias (controle: 10.395 ± 3.549um2; versus anti-M2: 4.561 ± 4.915um2; p=0,012). CONCLUSÕES: O recrutamento de leucócitos após a lesão vascular é dependente da interação alfaMbeta2-GP Ibalfa e a neutralização desta interação inibe a proliferação celular e a formação neointimal. / INTRODUCTION: The interaction between leukocytes and platelets is fundamental for the beginning and the progression of restenosis and atherosclerosis. Recent in vitro studies have shown that the leukocyte integrin Mac-1 binds to the platelet glycoprotein (GP) Ibalfa, and this interaction plays a central role in the leukocyte firm adhesion and transmigration at sites of platelet deposition. However, there is no in vivo study evaluating the importance of the integrin Mac-1 and GP Ibalfa (alfaMbeta2-GP Ibalfa) interaction in experimental models of vascular injury. METHODS: A peptide termed M2 or anti-M2 antibody was developed to block the leukocyte Mac-1 and platelet GP Ibalfa interaction, aiming to inhibit the adhesion of leukocytes to the platelet-coated surface of vessels as well as the cellular proliferation and the neointimal hyperplasia. The peptide was injected and compared with a control-antibody in C57B1/6J mice subjected to wire-induced femoral artery injury. One day (control: n= 6; anti-M2: n= 6), 5 days (control: n= 9; anti-M2: n= 9) or 28 days (control: n= 9; anti-M2: n= 9) after vascular injury, the femoral arteries were harvested for morphometry and immunohistochemistry. RESULTS: The alfaMbeta2-GP Ibalfa interaction blockade promoted a statistically significant 75% reduction in leukocytes in the medial layer on the first day after vascular injury (control: 7.9 ± 5.0% out of the total cells in the medial layer versus anti-M2: 2.0 ± 1.6%; p=0.021), as well as determined a statistically significant 42% decrease 5 days later (control: 42.3 ± 12.9% out of the total cells in the neointima versus anti-M2: 24.6 ± 10.8%; p=0.047), and a 58% decrease in leukocyte accumulation in the developing neointima 28 days later (control: 7.9 ± 3.0% versus anti-M2: 3.3 ± 1.3%; p=0.012). The cellular proliferation in the vessel medial layer 5 days after vascular injury presented a statistically significant 64% reduction by the alfaMbeta2-GP Ibalfa interaction blockade (control: 5.0 ± 2.9% out of the total cells in the medial layer versus anti-M2: 1.8 ± 0.5%; p=0.043), and there was also a significant 47% decrease in the vessel intimal layer cellular proliferation 28 days later (control: 3.8 ± 1.7% out of the total cells in the intimal layer versus anti-M2: 2.0 ± 1.2%; p=0.047). Furthermore, the alfaMbeta2-GP Ibalfa interaction blockade determined a statistically significant 56% reduction in the intimal thickening 28 days after vascular injury (control: 10,395 ± 3,549um2 versus anti-M2: 4,561 ± 4,915um2; p=0.012). CONCLUSIONS: The leukocyte recruitment after vascular injury depends on the alfaMbeta2-GP Ibalfa interaction, and its neutralization inhibits cellular proliferation and neointimal formation.

This thesis describes a comprehensive study of understanding the mechanism of rigidity sensing by quantitative analysis using submicron pillar array substrates. From mechanobiology perspective, we explore and study molecular pathways involved in rigidity and force sensing at cell-matrix adhesions with regard to cancer, regeneration, and development by quantification methods. In Chapter 2 and 3, we developed fabrication and imaging techniques to enhance the performance of a submicron pillar device in terms of spatial and temporal measurement ability, and we discovered a correlation of rigidity sensing forces and corresponding proteins involved in the early rigidity sensing events. In Chapter 2, we introduced optical effect arising from submicron structure imaging, and we described a technique to identify the correct focal plane of pillar tip by fabricating a substrate with designed-offset pillars. From calibration result, we identified the correct focal plane that was previously overlooked, and verified our findings by other imaging techniques. In Chapter 3, we described several techniques to selectively functionalize elastomeric pillars top and compared these techniques in terms of purposes and fabrication complexity. Techniques introduced in this chapter included direct labeling, such as stamping of fluorescent substances (organic dye, nano-diamond, q-dot) to pillars top, as well as indirect labeling that selectively modify the surface of molds with either metal or fluorescent substances. In Chapter 4, we examined the characteristics of local contractility forces and identified the components formed a sarcomere like contractile unit (CU) that cells use to sense rigidity. CUs were found to be assembled at cell edge, contain myosin II, α-actinin, tropomodulin and tropomyosin (Tm), and resemble sarcomeres in size (~2 μm) and function. Then we performed quantitative analysis of CUs to evaluate rigidity sensing activity over ~8 hours time course and found that density of CUs decrease with time after spreading on stiff substrate. However addition of EGF dramatically increased local contraction activity such that about 30% of the total contractility was in the contraction units. This stimulatory effect was only observed on stiff substrate not on soft. Moreover, we find that in the early interactions of cells with rigid substrates that EGFR activity is needed for normal spreading and the assembly of local contraction units in media lacking serum and any soluble EGF. In Chapter 5, we performed high temporal- and spatial-resolution tracking of contractile forces exerted by cells on sub-micron elastomeric pillars. We found that actomyosin-based sarcomere-like CUs simultaneously moved opposing pillars in net steps of ~2.5 nm, independent of rigidity. What correlated with rigidity was the number of steps taken to reach a force level that activated recruitment of α-actinin to the CUs. When we removed actomyosin restriction by depleting tropomyosin 2.1, we observed larger steps and higher forces that resulted in aberrant rigidity sensing and growth of non-transformed cells on soft matrices. Thus, we conclude that tropomyosin 2.1 acts as a suppressor of growth on soft matrices by supporting proper rigidity sensing.

Made available in DSpace on 2015-04-22T22:14:03Z (GMT). No. of bitstreams: 1 daniele barros de castro.pdf: 2223140 bytes, checksum: 269a3eddf50c97bcbed1bbb50151d917 (MD5) Previous issue date: 2010-09-10 / Conselho Nacional de Desenvolvimento Científico e Tecnológico / Hepatitis C is a major public health problem today, with approximately 170 million people infected worldwide. HCV is a highly immunogenic infectious agent leading to the development of an intense humoral and cellular response. However, about 80% of patients progress to a chronic disease may develop cirrhosis or liver cancer. The HCV infection of cells rapidly triggers intracellular signaling events leading to cytokine production and changes in the pattern of expression of cell adhesion molecules, providing a barrier to replication and viral spread. The aim of this study was to characterize the expression of adhesion molecules and cytokine profile in peripheral blood from blood donors of the Foundation HEMOAM HCV positive. For this, we analyzed blood samples from 50 individuals who were reactive in serological screening test for HCV, and as a negative control, we analyzed 53 samples of healthy blood donors. For analysis of expression of cell adhesion molecules in leukocytes, the samples were stained with monoclonal antibodies and analyzed by flow cytometry. Quantification of serum cytokine Th1, Th2 and Treg profile was performed by ELISA. The prevalence of HCV infection in the population of blood donors of the Foundation HEMOAM living in Manaus, from August/2009 to July/2010, was 0.1% and was greater prevalent in the group of first-time blood donors, compared to repeat blood donors. It was observed that the expression of cell adhesion molecules on leukocytes in peripheral blood is influenced by HCV infection, resulting in changes in the pattern of leukocyte recruitment to the liver and thus alters the course of the disease. There is evidence that the immune response against HCV in the population of blood donors, provide a toward Th1 profile, characterized by a high concentration of IL-12 and IL-10 in peripheral blood. The concentration of cytokines in peripheral blood from donors infected with HCV correlated with the expression pattern of cell adhesion molecules of leukocytes. However, our results reinforce the importance of the relationship between cell adhesion molecules, cytokine production and HCV infection. / A hepatite C é um grande problema de saúde pública atual, com aproximadamente 170 milhões de pessoas infectadas no mundo todo. O HCV é um agente infeccioso altamente imunogênico levando ao desenvolvimento de uma intensa resposta imune humoral e celular. Entretanto, cerca de 80% dos pacientes evoluem para uma doença crônica, podendo desenvolver cirrose hepática ou câncer. A infecção das células pelo HCV rapidamente desencadeia eventos sinalizadores intracelulares que levam à produção de citocinas e a mudanças no padrão de expressão de moléculas de adesão celular, propiciando uma barreira à replicação e à disseminação viral. O objetivo do presente estudo foi caracterizar a expressão de moléculas de adesão e o perfil de citocinas em sangue periférico de doadores de sangue da Fundação HEMOAM infectados pelo vírus da hepatite C. Para isso, foram analisadas amostras de sangue de 50 indivíduos que apresentaram reatividade nos teste da triagem sorológica para HCV e, como controle negativo, foram analisadas 53 amostras de doadores de sangue saudáveis. Para fenotipagem dos leucócitos quanto a expressão de moléculas de adesão celular as amostras foram marcadas com anticorpos monoclonais e analisadas por citometria de fluxo. A quantificação da concentração sérica das citocinas de perfil Th1, Th2 e Treg foi realizada por ELISA. A prevalência de infecção por HCV na população de doadores de sangue da Fundação HEMOAM, residentes em Manaus, no período de agosto/2009 a julho/2010, foi de 0,1%, sendo mais prevalente no grupo de primodoadores, quando comparado aos doadores de repetição. Foi observado que a expressão das moléculas de adesão celular em leucócitos no sangue periférico é influenciada pela infecção por HCV, o que resulta em alterações no padrão de recrutamento de leucócitos para o fígado e, consequentemente, altera o curso da doença. Há evidências de que a resposta imune contra o HCV, na população de doadores de sangue, apresente uma polarização para o perfil Th1, caracterizada por uma alta concentração de IL-12 e IL-10 no sangue periférico. A concentração de citocinas no sangue periférico de doadores infectados pelo HCV apresentou correlação com o padrão de expressão de moléculas de adesão celular dos leucócitos. Contudo, nossos resultados reforçam a importância da relação entre as moléculas de adesão celular, a produção de citocinas e a infecção pelo HCV.

A hidroquinona (HQ) é um composto fenólico obtido a partir da metabolização endógena do benzeno, está presente no cigarro, medicamentos, reveladores fotográficos, alimentos e plantas medicinais. Temos demonstrado que a intoxicação experimental de ratos à HQ compromete a migração de leucócitos para o pulmão na vigência de resposta inflamatória alérgica ou inespecífica. O presente trabalho visou avaliar os efeitos da HQ sobre atividades da célula endotelial e de neutrófilos envolvidas na inflamação. Culturas primárias de células endoteliais da rede microcirculatória obtidas do músculo cremaster de ratos Wistar, machos, foram tratadas com HQ (10 ou 100 µM, 2 horas) e posteriormente incubadas ou não com LPS de E. coli (LPS; 2 µg/mL). Neutrófilos obtidos da cavidade peritoneal de ratos Wistar, 4 horas após a injeção local de glicogênio de ostra (10 mL, 1%) , foram tratados com HQ (5 ou 10 µM, 1 hora) e, em seguida, foram incubados ou não com LPS (5 µg/mL). Células controles receberam volumes equivalentes dos veículos da HQ e do LPS. Os dados obtidos mostram que o tratamento com a HQ não induziu necrose ou apoptose em ambos os tipos celulares; reduziu a produção de NO pela célula endotelial e por neutrófilos, por bloqueio das atividades das óxido nítrico sintases; reduziu a expressão gênica e protéica de TNF-α, IL-6 e IL-1β induzida pelo LPS em neutrófilos, possivelmente decorrente de redução da translocação nuclear do NFκB; por outro lado aumentou a expressão gênica e protéica basal de TNF-α, IL-1β, ICAM-1, PECAM-1 e VCAM-1, bem como a translocação nuclear do NF-κB; reduziu a atividade fagocítica e microbicida de neutrófilos frente a Candida albicans; não afetou a expressão gênica da CYP2E1 em ambos os tipos celulares, mas aumentou a expressão gênica de MPO em neutrófilos. Em conjunto, os dados permitem concluir que a HQ atua diferentemente nos dois tipos de células estudadas, ativando e inibindo propriedades inflamatórias na célula endotelial e nos neutrófilos, respectivamente. É possível as ações sobre os neutrófilos possam contribuir, pelo menos em parte, pela redução da migração celular durante a resposta inflamatória observada após exposição in vivo à HQ. / Hydroquinone (HQ) is a fenolic compound obtained after benzene metabolism, it is a component of cigarette, medicines, photographic developer, and it is also finding in some foods and medicinal herbs. Our research group has been shown that rats in vivo exposed to HQ present impaired leukocyte migration into lung during allergic or non-specific inflammation. In the present study, we investigate the effects of HQ on functional activities of neutrophils and endothelial cells (EC) involved in inflammation. Primary cultured EC was obtained from microcirculatory network of male Wistar rats, and treated with HQ (10 or 100 µM, two hours). After the treatments, EC was incubated in presence or absence of lipopolissacharide of E. coli (LPS; 2 µg/mL). Peritoneal neutrophils obtained four hours after local injection of oyster glycogen (10 mL, 1%) were incubated with HQ (5 or 10 µM, one hour) and in sequence it was incubated in presence or absence of LPS (5 µg/mL) .Control cells were cultured with equivalent volumes of HQ and LPS vehicle. Results obtained showed that treatment with HQ did not induce apoptosis or necrosis in both types of cells; impaired NO production by endothelial cells and neutrophils dependent on blockade of Ca+2-dependent and independent NOS activity; decreased gene and protein expression of TNF-α, IL-6 and IL-1β in neutrophils induced by LPS, possibly due to reduced nuclear translocation of the NF-κB. On the other hand, HQ treatment enhanced basal protein and gene expression of TNF-α, IL-1β , ICAM-1, PECAM-1 and VCAM-1 and the nuclear translocation of NF-κB; impaired Candida albicans phagocytic and killing indexes; did not affect the gene expression of CYP2E1 in both types of cell, but increased the gene expression of MPO in neutrophils. Taken together, results obtained show that HQ acts differently in the two types of cells studied, activating and inhibiting inflammatory properties in endothelial cells and neutrophils, respectively. Actions on neutrophils may contribute, at least in part, on the reduced leukocyte recruitment during in vivo HQ exposure.

The pathophysiology of atherosclerotic cardiovascular disease (CVD) is highlighted by vascular dysfunction and low-grade vascular inflammation. Furthermore, the site-specific distribution of atherosclerosis throughout the arterial vasculature is primarily determined by local hemodynamic force. Therefore, this dissertation outlines three experiments designed to investigate the role of acute mental and physical (i.e., aerobic exercise), and vascular wall shear stress (SS) on the inflammatory aspects of atherosclerosis. Chapter 2 examines the effect of acute laboratory-induced mental stress on intracellular pro-inflammatory signaling pathways in peripheral blood mononuclear cells. Chapter 3 investigates the impact of acute laboratory-induced mental stress and maximal aerobic exercise on the concentration of soluble VCAM-1 (sVCAM-1) and CX3CL1/fractalkine (sCX3CL1) in human serum. Lastly, Chapter 4 examines the role of short- (30 min) and long-term (24 hr) low-to-negative oscillating SS (LOSS) and high laminar SS (HLSS) on the expression and secretion (i.e., cleavage) of cell-membrane VCAM-1 and CX3CL1 by human umbilical vein endothelial cell cultures in vitro. Together, these experiments provide evidence that acute psychological stress, maximal aerobic exercise, and HLSS influence vascular inflammation and adhesive properties of the vessel wall. More specifically, the results from Chapter 2 provide evidence that acute mental stress promotes the immune-cell mediated synthesis of pro-inflammatory cytokines in circulation. In addition, Chapter 3 and Chapter 4 demonstrate that the elevations in blood flow and hemodynamic force associated with maximal aerobic exercise, and unidirectional high SS may have the capacity to alter the expression of endothelial-bound cellular adhesion molecules, in part by eliciting their release from the vessel wall.

"December 2004" / Includes bibliographical references (leaves 342-379) / xiii, 379 leaves : ill. (col.) ; 30 cm. / Title page, contents and abstract only. The complete thesis in print form is available from the University Library. / Thesis (Ph.D.)--University of Adelaide, Dept. of Medicine, 2005

Hypothermia therapy (HT) is used clinically following global cerebral ischemia (GCI) but its therapeutic mechanisms are not completely understood. An elucidation of such mechanisms may lead to novel therapeutic approaches that improve patient outcome. Using a murine model of GCI, we determined the effect of HT on the expression of inflammatory proteins in the hippocampus and serum. We also examined its effect on microglia/macrophage activation and neurodegeneration in the brain at 72 hours following ischemia, and its effect on long-term spatial memory/learning and contextual fear response. GCI led to increased neurodegeneration and microglia/macrophage activation in the hippocampus, and increased IL-1β and KC protein expression in the hippocampus at 72 hours. Hypothermia therapy attenuated these inflammatory responses. It also improved spatial learning/memory at 7 and 21 days, and preserved contextual fear response 21 days post-ischemia. Hypothermia therapy attenuated the post-ischemic inflammatory response, protected hippocampal neurons, and preserved long-term memory and learning.

Hypothermia therapy (HT) is used clinically following global cerebral ischemia (GCI) but its therapeutic mechanisms are not completely understood. An elucidation of such mechanisms may lead to novel therapeutic approaches that improve patient outcome. Using a murine model of GCI, we determined the effect of HT on the expression of inflammatory proteins in the hippocampus and serum. We also examined its effect on microglia/macrophage activation and neurodegeneration in the brain at 72 hours following ischemia, and its effect on long-term spatial memory/learning and contextual fear response. GCI led to increased neurodegeneration and microglia/macrophage activation in the hippocampus, and increased IL-1β and KC protein expression in the hippocampus at 72 hours. Hypothermia therapy attenuated these inflammatory responses. It also improved spatial learning/memory at 7 and 21 days, and preserved contextual fear response 21 days post-ischemia. Hypothermia therapy attenuated the post-ischemic inflammatory response, protected hippocampal neurons, and preserved long-term memory and learning.

Adhesion of sickle erythrocytes to vascular endothelium may initiate or propagate occlusive events in sickle cell anemia, many of which are accompanied by infection and the associated inflammatory response. Inflammatory markers are also present in sickle patients during asymptomatic periods. Inflammatory cytokines upregulate expression of endothelial adhesion molecules that promote adhesion of sickle erythrocytes. The data in this work demonstrate that after 2 hrs of stimulation with the cytokine TNF- and alpha;, E-selectin, but not VCAM-1 is upregulated on human dermal microvascular endothelial cells. After 6 hrs of TNF- and alpha; stimulation, both VCAM-1 and E-selectin expression are upregulated on MECs, and sickle erythrocytes bind to both receptors. Because strategies to control inflammation-associated adhesion in vivo may need to account for both VCAM-1 and E-selectin mediated events, control of intracellular signaling pathways leading to receptor expression is an attractive strategy for inhibiting adhesion. Cyclic AMP and nitric oxide are two intracellular signaling molecules important to cytokine-induced receptor expression. The data in this work demonstrate that TNF- and alpha; induced VCAM-1 and E-selectin expression on endothelial cells and sickle erythrocyte adhesion are abated by increasing endothelial cyclic AMP concentrations using Forskolin, IBMX, or Bt2cAMP. Conversely, when sickle erythrocytes, rather than endothelial cells, are treated with reagents that increase intracellular cAMP, adhesion to unstimulated endothelial cells is increased in some patients. Treatment of endothelial cells with reagents such as SNP and DETA-NO that increase nitric oxide significantly inhibits VCAM-1, but not E-selectin expression, induced by TNF- and alpha; stimulation and significantly inhibits sickle erythrocyte adhesion. Treatment of sickle erythrocytes directly with these reagents may also inhibit adhesion. Together these data suggest that cAMP- and nitric oxide-dependent signaling are useful therapeutic targets to inhibit cytokine-induced sickle erythrocyte adhesion to endothelium.

[Truncated abstract] Melanoma cell adhesion molecule (MCAM) is highly expressed in more than 70% of metastatic melanoma and is correlated with invasive potential. However, the specific contribution MCAM makes to invasion and metastasis in melanoma is not clear. In this study, I have demonstrated that transfection of MCAM into MCAM-negative melanoma and CHO cells leads to changes in cell shape, and the modulation of cell-to-cell and cell-matrix interactions. MCAM positive cells were slower to spread on collagen type I, collagen type IV and laminin 1 than MCAM negative cells, although these differences were not apparent on vitronectin, fibronectin and laminin 10. In contrast, MCAM expression had little effect on cell adhesion to any of the matrices tested. MCAM positive (compared to negative) cells also showed morphological changes and a rearrangement of the actin cytoskeleton when plated on a matrix containing laminin 5. Taken together, these data suggest that MCAM expression modulates β1-integrinmediated spreading on matrix, but has little effect on αvβ3-mediated cell-matrix interactions. As this study provided little evidence to suggest that MCAM transfection altered β1 integrin expression levels on melanoma cells, it is proposed that a competitive interaction between the cytoplasmic domains of MCAM and β1 integrin may affect mature focal adhesion assembly. MCAM expression in melanoma cells was also associated with decreased cell movement over matrix into a scratch-wound site and an increased tendency to form cell cords on Matrigel. These two assays gauge the propensity of a cell to engage in cell-cell versus cell-matrix interactions, and suggest that MCAM positive cells favour cell-cell adhesion. Interestingly, MCAM transfection was also associated with an increased ability of melanoma cells to migrate through a basement membrane towards a chemoattractant. ... Analysis of the intracellular domain of MCAM revealed the presence of tyrosine and dileucine endocytosis signals. Interestingly, disruption of these two motifs did not seem to impair the internalization of MCAM from the cell surface. The di-leucine motif, however, was necessary for the recycling of MCAM back to the surface following endocytosis. Lastly, MCAM was found to exists as dimers within the cell membrane in the absence of ligand, although the exact location of the dimerization motif is not yet clearly defined. Collectively, findings from my study suggest: MCAM expression in melanoma cells facilitates cell-cell interactions, whilst concomitantly modulating cell-matrix interactions. MCAM transfection also leads to enhanced migration of melanoma cells through a basement membrane. Thus, MCAM expression may increase the ability of melanoma cells to migrate as a collective, a feature of highly invasive cancer. The intracellular domain of MCAM interacts with ApxL2, a novel member of the Shroom family of actin-binding proteins. It is likely that ApxL2 links a proportion of MCAM within the cell to the actin cytoskeleton, contributing to cell shape determination and other processes, such as migration. MCAM exists as dimers on the cell surface and is internalized at least partially by a clathrin-mediated mechanism.